Cargando…
Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma
PURPOSE: Because of the poor prognosis for high-grade glioma (HGG) patients, it is important to increase the dose of the tumor to improve the efficacy while minimizing the dose of organs at risk (OARs). Thus, we evaluated the potential dosimetric gains of helical tomotherapy (HT) versus intensity-mo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109582/ https://www.ncbi.nlm.nih.gov/pubmed/32258121 http://dx.doi.org/10.1155/2020/4258989 |
_version_ | 1783512983739039744 |
---|---|
author | Liu, Pei Liu, Gui Wang, Guihua Zhou, Weibing Sun, Yangqing Chen, Wen Zeng, Qian Hong, Jidong Xie, Qiongxuan Ou, Ludi Wei, Rui |
author_facet | Liu, Pei Liu, Gui Wang, Guihua Zhou, Weibing Sun, Yangqing Chen, Wen Zeng, Qian Hong, Jidong Xie, Qiongxuan Ou, Ludi Wei, Rui |
author_sort | Liu, Pei |
collection | PubMed |
description | PURPOSE: Because of the poor prognosis for high-grade glioma (HGG) patients, it is important to increase the dose of the tumor to improve the efficacy while minimizing the dose of organs at risk (OARs). Thus, we evaluated the potential dosimetric gains of helical tomotherapy (HT) versus intensity-modulated radiotherapy (IMRT) or volume-modulated arc therapy (VMAT) for high-grade glioma (HGG). METHODS: A total of 42 HGG patients were retrospectively selected who had undergone helical tomotherapy; then, IMRT and VMAT plans were generated and optimized for comparison after contouring crucial neuronal structures for neurogenesis and neurocognitive function. IMRT and VMAT were optimized with the Eclipse treatment planning system (TPS) (Version 11.0.31) and HT using TomoTherapy Hi-Art Software (Version 2.0.7) (Accuray, Madison, WI, USA). All three techniques were optimized for simultaneously delivering 60 Gy to planning target volume (PTV) 1 and 50-54 Gy to PTV2. We also analyzed the homogeneity index (HI) and conformity index (CI) of PTVs and organ at risk (OAR) sparing. RESULTS: There was no significant difference in the PTV coverage among IMRT, VMAT, or HT. As for the HI, HT plans (PTV1 HI: 0.09 ± 0.03, PTV2 HI: 0.17 ± 0.05) had the best homogeneity when compared to IMRT plans (PTV1 HI: 0.10 ± 0.04, PTV2 HI: 0.18 ± 0.04) and VMAT plans (PTV1 HI: 0.11 ± 0.03, PTV2 HI: 0.20 ± 0.03). The CI value of HT (PTV1 CI: 0.98 ± 0.03, PTV2: 0.98 ± 0.05) was closest to the optimal value. Except for the IMRT and VMAT groups, there were statistically significant differences between the other two groups of the CI values in both PTV1 and PTV2. The other comparison values were statistically significant except for the optic nerve, and VMAT had the best sparing of the optic chiasm. The mean and max doses of OARs declined significantly in HT. CONCLUSIONS: For high-grade glioma patients, HT had superior outcomes in terms of PTV coverage and OAR sparing as compared with IMRT/VMAT. |
format | Online Article Text |
id | pubmed-7109582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-71095822020-04-04 Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma Liu, Pei Liu, Gui Wang, Guihua Zhou, Weibing Sun, Yangqing Chen, Wen Zeng, Qian Hong, Jidong Xie, Qiongxuan Ou, Ludi Wei, Rui Biomed Res Int Research Article PURPOSE: Because of the poor prognosis for high-grade glioma (HGG) patients, it is important to increase the dose of the tumor to improve the efficacy while minimizing the dose of organs at risk (OARs). Thus, we evaluated the potential dosimetric gains of helical tomotherapy (HT) versus intensity-modulated radiotherapy (IMRT) or volume-modulated arc therapy (VMAT) for high-grade glioma (HGG). METHODS: A total of 42 HGG patients were retrospectively selected who had undergone helical tomotherapy; then, IMRT and VMAT plans were generated and optimized for comparison after contouring crucial neuronal structures for neurogenesis and neurocognitive function. IMRT and VMAT were optimized with the Eclipse treatment planning system (TPS) (Version 11.0.31) and HT using TomoTherapy Hi-Art Software (Version 2.0.7) (Accuray, Madison, WI, USA). All three techniques were optimized for simultaneously delivering 60 Gy to planning target volume (PTV) 1 and 50-54 Gy to PTV2. We also analyzed the homogeneity index (HI) and conformity index (CI) of PTVs and organ at risk (OAR) sparing. RESULTS: There was no significant difference in the PTV coverage among IMRT, VMAT, or HT. As for the HI, HT plans (PTV1 HI: 0.09 ± 0.03, PTV2 HI: 0.17 ± 0.05) had the best homogeneity when compared to IMRT plans (PTV1 HI: 0.10 ± 0.04, PTV2 HI: 0.18 ± 0.04) and VMAT plans (PTV1 HI: 0.11 ± 0.03, PTV2 HI: 0.20 ± 0.03). The CI value of HT (PTV1 CI: 0.98 ± 0.03, PTV2: 0.98 ± 0.05) was closest to the optimal value. Except for the IMRT and VMAT groups, there were statistically significant differences between the other two groups of the CI values in both PTV1 and PTV2. The other comparison values were statistically significant except for the optic nerve, and VMAT had the best sparing of the optic chiasm. The mean and max doses of OARs declined significantly in HT. CONCLUSIONS: For high-grade glioma patients, HT had superior outcomes in terms of PTV coverage and OAR sparing as compared with IMRT/VMAT. Hindawi 2020-03-18 /pmc/articles/PMC7109582/ /pubmed/32258121 http://dx.doi.org/10.1155/2020/4258989 Text en Copyright © 2020 Pei Liu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Liu, Pei Liu, Gui Wang, Guihua Zhou, Weibing Sun, Yangqing Chen, Wen Zeng, Qian Hong, Jidong Xie, Qiongxuan Ou, Ludi Wei, Rui Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title | Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title_full | Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title_fullStr | Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title_full_unstemmed | Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title_short | Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma |
title_sort | comparison of dosimetric gains provided by intensity-modulated radiotherapy, volume-modulated arc therapy, and helical tomotherapy for high-grade glioma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109582/ https://www.ncbi.nlm.nih.gov/pubmed/32258121 http://dx.doi.org/10.1155/2020/4258989 |
work_keys_str_mv | AT liupei comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT liugui comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT wangguihua comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT zhouweibing comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT sunyangqing comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT chenwen comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT zengqian comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT hongjidong comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT xieqiongxuan comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT ouludi comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma AT weirui comparisonofdosimetricgainsprovidedbyintensitymodulatedradiotherapyvolumemodulatedarctherapyandhelicaltomotherapyforhighgradeglioma |